3 Firms Guide Vertex's $10B Buy Of Crinetics Pharmaceuticals
Kirkland & Ellis LLP is advising Vertex Pharmaceuticals Inc. in its $10 billion acquisition of Crinetics Pharmaceuticals Inc., which is being represented by both Paul Weiss Rifkind Wharton & Garrison LLP...To view the full article, register now.
Already a subscriber? Click here to view full article